Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure

This publication has 50 references indexed in Scilit:

• Role of Asymmetrical Dimethylarginine in Inflammation-Induced Endothelial Dysfunction in Human Atherosclerosis
  Hypertension, 2011
• Inflammation and Asymmetric Dimethylarginine for Predicting Death and Cardiovascular Events in ESRD Patients
  Clinical Journal of the American Society of Nephrology, 2011
• Renal Failure in Cirrhosis
  New England Journal of Medicine, 2009
• Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality†‡§
  Hepatology, 2009
• Homocysteine and endothelial markers are increased in patients with chronic liver diseases
  European Journal of Internal Medicine, 2009
• Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community
  Circulation, 2009
• TNF-α activation of arterioles and venules alters distribution and levels of ICAM-1 and affects leukocyte-endothelial cell interactions
  American Journal of Physiology-Heart and Circulatory Physiology, 2006
• A Randomized Unblinded Pilot Study Comparing Albumin Versus Hydroxyethyl Starch in Spontaneous Bacterial Peritonitis * #
  Hepatology, 2005
• Novel Role for Albumin in Innate Immunity: Serum Albumin Inhibits the Growth ofBlastomyces dermatitidisYeast Form In Vitro
  Infection and Immunity, 2003
• An Essential Role for Albumin in the Interaction of Endotoxin with Lipopolysaccharide-binding Protein and sCD14 and Resultant Cell Activation
  Journal of Biological Chemistry, 2002